Pembrolizumab: a beacon of hope for clear-cell renal-cell carcinoma patients post-nephrectomy

被引：0

作者：

Anand, Ayush ^{[1
,2
]}

Banda, Godfrey T. ^{[12
]}

Satapathy, Prakasini ^{[3
,13
]}

Sharma, Rakesh Kumar ^{[4
,5
]}

Sharma, Divya ^{[7
]}

Arora, Mithhil ^{[8
]}

Khatib, Mahalaqua Nazli ^{[9
]}

Gaidhane, Shilpa ^{[10
]}

Zahiruddin, Quazi Syed ^{[11
]}

Rustagi, Sarvesh ^{[6
]}

机构：

[1] BP Koirala Inst Hlth Sci, Dharan, Nepal

[2] MediSurg Res, Darbhanga, India

[3] Saveetha Univ, Saveetha Med Coll & Hosp, Saveetha Inst Med & Tech Sci, Ctr Global Hlth Res, Chennai, India

[4] Graph Era, Dehra Dun, India

[5] Graph Era Hill Univ, Clement Town, India

[6] Uttaranchal Univ, Sch Appl & Life Sci, Dehra Dun, Uttarakhand, India

[7] Chitkara Univ, Ctr Res Impact & Outcome, Rajpura, Punjab, India

[8] Chitkara Univ, Chitkara Ctr Res & Dev, Baddi, Himachal Prades, India

[9] Global Consortium Publ Hlth & Res, Div Evidence Synth, Miami, FL USA

[10] Jawaharlal Nehru Med Coll, One Hlth Ctr COHERD, Belgaum, India

[11] Datta Meghe Inst Higher Educ, South Asia Infant Feeding Res Network SAIFRN, Global Consortium Publ Hlth & Res, Div Evidence Synth, Wardha, India

[12] Kamuzu Univ Hlth Sci, Blantyre 30184, Malawi

[13] Al Mustaqbal Univ, Med Labs Tech Dept, Hillah, Babil, Iraq

来源：

INTERNATIONAL JOURNAL OF SURGERY OPEN | 2024年 / 62卷 / 04期

关键词：

ADJUVANT PEMBROLIZUMAB;

D O I：

10.1097/IO9.0000000000000085

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

引用

页码：493 / 495

页数：3

共 50 条

[31] PARD3 Protein Overexpression Is Associated with Poor Survival of Patients with Clear-Cell Renal-Cell Carcinoma
Dugay, F.
LeGoff, X.
Chesnel, F.
Verhoest, G.
Jouan, F.
Henry, C.
Vigneau, C.
Rioux-Leclercq, N.
Arlot-Bonnemains, Y.
Belaud-Rotureau, M-A
MODERN PATHOLOGY, 2013, 26 : 207A - 207A
[32] PARD3 Protein Overexpression Is Associated with Poor Survival of Patients with Clear-Cell Renal-Cell Carcinoma
Dugay, F.
LeGoff, X.
Chesnel, F.
Verhoest, G.
Jouan, F.
Henry, C.
Vigneau, C.
Rioux-Leclercq, N.
Arlot-Bonnemains, Y.
Belaud-Rotureau, M-A
LABORATORY INVESTIGATION, 2013, 93 : 207A - 207A
[33] Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma
Palumbo, Carlotta
Mistretta, Francesco A.
Knipper, Sophie
Pecoraro, Angela
Tian, Zhe
Dzyuba-Negrean, Cristina
Shariat, Shahrokh F.
Saad, Fred
Simeone, Claudio
Berruti, Alfredo
Briganti, Alberto
Kapoor, Anil
Antonelli, Alessandro
Karakiewicz, Pierre I.
CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : E730 - E738
[34] Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma
Zaridze, D. G.
Mazurenko, N. N.
Bezhanova, S. D.
Maksimovich, D. M.
Shangina, O., V
Draudin-Krylenko, V. A.
Mukeria, A. F.
Matveev, V. B.
ONKOUROLOGIYA, 2019, 15 (01): : 23 - 31
[35] Sorafenib in advanced clear-cell renal-cell carcinoma (vol 356, pg 125, 2007)
Escudier, Bernard
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (02): : 203 - 203
[36] Paraneoplastic digital ischemia in clear-cell renal-cell carcinoma: Report of a case and review of the literature
Kampoli, Katerina
Gardeli, Dimitra
Mouktaroudi, Maria
Fanouriakis, Antonis
Lazaris, Andreas M.
Koumarianou, Anna
UROLOGIA JOURNAL, 2019, 86 (03) : 156 - 160
[37] Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma
Mueller, Tim
Tolkach, Yuri
Stahl, David
Steiner, Susanne
Hauser, Stefan
Ellinger, Jorg
Rabien, Anja
Ralla, Bernhard
Jung, Klaus
Stephan, Carsten
Kristiansen, Glen
CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : E167 - E175
[38] Acute kidney injury from post-nephrectomy renal cell carcinoma thrombus
Plamm, Alex
Vijayan, Madhusudan
Marinelli, Brett
Vassalotti, Joseph A.
Winston, Jonathan
Rein, Joshua L.
KIDNEY INTERNATIONAL, 2022, 102 (06) : 1431 - 1431
[39] PARTIAL NEPHRECTOMY FOR RENAL-CELL CARCINOMA
NOVICK, AC
UROLOGY, 1995, 46 (02) : 149 - 152
[40] NEPHRECTOMY IN METASTATIC RENAL-CELL CARCINOMA
FOWLER, JE
UROLOGIC CLINICS OF NORTH AMERICA, 1987, 14 (04) : 749 - 756

← 1 2 3 4 5 →